Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Values of Serum Soluble CD14 Subtype and CD88 Monitoring in Critically Ill Patients.

NCT02120534 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT02120534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02120534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Values of Serum Soluble CD14 Subtype and CD88 Monitoring in Critically Ill Patients.
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
October 31, 2014
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis